Cysteinyl leukotriene receptor 1 modulates autophagic activity in retinal pigment epithelial cells

The retinal pigment epithelium (RPE), which is among the tissues in the body that are exposed to the highest levels of phagocytosis and oxidative stress, is dependent on autophagy function. Impaired autophagy and continuous cellular stress are associated with various disorders, such as dry age-relat...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 10; no. 1; p. 17659
Main Authors Koller, Andreas, Bruckner, Daniela, Aigner, Ludwig, Reitsamer, Herbert, Trost, Andrea
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 19.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The retinal pigment epithelium (RPE), which is among the tissues in the body that are exposed to the highest levels of phagocytosis and oxidative stress, is dependent on autophagy function. Impaired autophagy and continuous cellular stress are associated with various disorders, such as dry age-related macular degeneration (AMD), a disease for which effective therapies are lacking. Cysteinyl leukotriene receptor (CysLTR) 1 is a potential modulator of autophagy; thus, the aim of this study was to investigate the role of CysLTR1 in autophagy regulation in the RPE cell line ARPE-19. The polarized ARPE-19 monolayer exhibited expression of CysLTR1, which was colocalized with β-tubulin III. In ARPE-19 cells, autophagic activity was rhythmically regulated and was increased upon CysLTR1 inhibition by Zafirlukast (ZK) treatment. H 2 O 2 affected the proautophagic regulatory effect of ZK treatment depending on whether it was applied simultaneously with or prior to ZK treatment. Furthermore, mRNA levels of genes related to the leukotriene system, autophagy and the unfolded protein response were positively correlated. As CysLTR1 is involved in autophagy regulation under basal and oxidative stress conditions, a dysfunctional leukotriene system could negatively affect RPE functions. Therefore, CysLTR1 is a potential target for new treatment approaches for neurodegenerative disorders, such as AMD.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-020-74755-w